期刊文献+

端粒和端粒酶与心血管疾病关系 被引量:1

暂未订购
导出
摘要 端粒长度、端粒酶活性在心血管疾病发生发展过程中的变化引起了心血管界的关注。现就端粒、端粒酶与高血压、动脉粥样硬化、心肌细胞损伤、心力衰竭等心血管疾病的关系和研究状况作一综述。
出处 《岭南心血管病杂志》 2008年第3期220-222,共3页 South China Journal of Cardiovascular Diseases
  • 相关文献

参考文献23

  • 1EDO M D, ANDRES V. Aging, telomeres, and atherosclerosis [J]. Cardiovasc Res, 2005, 66 (2) : 213- 221.
  • 2邓辉胜,吕麟亚,李家富,魏宗德,薛莉.高血压病肠系膜动脉平滑肌细胞端粒酶活性表达的研究[J].泸州医学院学报,2003,26(1):10-11. 被引量:1
  • 3谭浩,李登清,黄民主.高血压病患者淋巴细胞端粒酶活性的研究[J].实用预防医学,2005,12(1):13-15. 被引量:4
  • 4JEANCLOS E, SCHORK N J, KYVIK K O, et al. Telomere length inversely correlates with pulse pressure and is highly familial[J]. Hypertension, 2000, 36 (2): 195-200.
  • 5BENETOS A, OKUDA K, LAJEMI M, et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity [ J ]. Hypertension, 2001, 37 (2 Part 2): 381-385.
  • 6DEMISSIE S, LEVY D, BENJAMIN E J, et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study[J]. Aging Cell, 2006, 5 (4): 325-330.
  • 7SAMANI N J, BOULTBY R, BUDER R, et al. Telomere shortening in atherosclerosis [ J ]. Lancet, 2001, 358 (9280) : 472.
  • 8OGAMI M, IKURA Y, OHSAWA M, et al. Telomere shortening in human coronary artery diseases [J ]. Arterioscler Thromb Vasc Biol, 2004, 24 (3) : 546-550.
  • 9BENETOS A, GARDNER J P, ZUREIK M, et al. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects [J]. Hypertension, 2004, 43 (2) : 182-185.
  • 10薛枫,宋建平,程绪杰,李红霞,蒋廷波,杨向军,刘志华,蒋文平.冠状动脉粥样硬化患者外周血白细胞端粒长度研究及意义[J].江苏医药,2004,30(4):273-275. 被引量:3

二级参考文献37

  • 1王颖,涂欣,燕树勋,涂晋文,田金洲.大鼠心肌梗死后心肌细胞核分裂指数及心肌肌动蛋白表达变化[J].中国综合临床,2006,22(6):481-484. 被引量:1
  • 2Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science, 1998, 279 : 349-352.
  • 3Kirchhoff C, Araki Y, Huhtaniemi I, et al. Immortalization by large T-antigen of the adult epididymal duct epithelium. Mol Cell Endocrinol, 2004, 216 : 83-94.
  • 4Kiyono T, Foster SA, Koop JI, et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature, 1998, 396 : 84-88.?A[4]Jha KK, Banga S, Palejwala V, et al. SV40-Mediated immortalization. Exp Cell Res, 1998, 245 : 1-7.?A
  • 5Newbold RF. The significance of telomerase activation and cellular immortalization in human cancer. Mutagenesis, 2002, 17 : 539-550.
  • 6Harada K, Arita K, Kurisu K, et al. Telomerase activity and the expression of telomerase components in pituitary adenoma with malignant transformation. Surg Neurol, 2000, 53 : 267-274.
  • 7Jaffe EA. Culture of human endothelial cells. Transplant Proc, 1980, 12(3 Suppl 1) : 49-53.
  • 8Burnham EL, Moss M, Harris F, et al. Elevated plasma and lung endothelial selectin levels in patients with acute respiratory distress syndrome and a history of chronic alcohol abuse. Crit Care Med, 2004, 32 : 675-679.
  • 9Jaye M, Lynch KJ, Krawiec J, et al. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet, 1999, 21: 424-428.
  • 10Che W, Lerner-Marmarosh N, Huang Q, et al. Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappa(B) activation and adhesion molecule expression. Circ Res, 2002, 90 : 1222-1230.

共引文献14

同被引文献43

  • 1范林,陈良龙,林朝贵.端粒与冠心病[J].国际心血管病杂志,2007,34(3):153-156. 被引量:1
  • 2Lin KW, Yan J. The telomere length dynamic and methods of its assessment. J Cell Mol Med, 2005,9:977-989.
  • 3O' Connor MS, Safari A, Liu D, et al. The human Rapl protein complex and modulation of telomere length. J Biol Chem, 2004,279:28585-28591.
  • 4Wang F, Podell ER, Zaug AJ, et al. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature, 2007,445 : 506-510.
  • 5Wong LS, Oeseburg H, de Boer RA, et al. Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing. Cardiovasc Res, 2009,81:244-252.
  • 6Campisi J. From cells to organisms: Can we learn about aging from ceils in culture? Exp Gerontol, 2001,36:607-618.
  • 7Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res, 1991,256:271-282.
  • 8Takubo K, fzumiyama-Shimomura N, Honma N, et al. Telomere lengths are characteristic in each human individual. Exp Gerontol, 2002,37 : 523 -531.
  • 9Ulaner GA, Hu J-F, Vu TH, et al. Tissue-specific 'alternate splicing of human telomerase reverse transcriptase (HTERT) in- fluences telomere lengths during human development, lntl J Cancer, 2002,91 : 644-649.
  • 10Friedrich U, Griese EU, Schwab M, et al. Telomere length in different tissues of elderly patients. Mech Aging Dev, 2000, 119:89-99.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部